Dr. Jinwei Zhang

Dr.Jinwei Zhang obtained his Ph.D degree in Biochemistry from Newcastle University, UK. He is currently a Principal Investigator at the University of Exeter, UK. His laboratory studies ion channels, transporters, and signalling pathways that associated with human diseases, for examples, stroke that regulated by WNK-SPAK/OSR1-KCC2/NKCC1, hypertension that regulated by WNK-SPAK/OSR1-NCC, and concern with elucidating and targeting ion transporters, kinases, protein-protein interactions using genetic mouse models, small molecules and CRISPR/Cas9 knock-in and knock-out technologies to aid discovery and validation of new potential drug targets. He is also interested in exploring marine microbial-derived molecules and their potential applications. He has published more than 100 articles in journals including Cell, Nature Medicine, Cell Metabolism, Neuron, Molecular Psychiatry, Nature Communications (x3), Acta Pharmacologica Sinica-B, Environ Sci Technol, EMBO Mol Med, Stroke, Science Signalling (x7), Journal of Neuroinflammation, Genetics in Medicine, Journal of Pharmaceutical Analysis, eLife, EMBO Rep, Acta Pharmacologica Sinica (x2), Inflammation Research, Cells, Hum Mol Genet (x2), FASEB J, Biochem J, ACS Chem Biol, Eur J Med Chem, J Pharm Biomed Anal , ACS Med Chem Lett (x2), Bioorg Med Chem Lett (x2), Expert Opin Ther Targets, Expert Opin Investig Drugs, J. Cell Sci., Neurosurgery, Int. J. Mol. Sci.(x2), Am. J. Physiol. Renal Physiol., Frontiers in Microbiology (x2), Frontiers in Pharmacology (x2), Frontiers in Physiology , Frontiers in Cellular Neurosciences, Pharmaceutics, Neurochemistry International, Journal of Visualized Experiments, The Journal of Physical Chemistry B, Mar Biotechnol (x2), PLOS One (x2), Current Medicinal Chemistry, Current Opinion in Pediatrics, IJSEM, J Microbiol Biotechnol, World J Microbiol Biotechnol (x2), IBRO Neuroscience Reports, Brain‐X, Journal of Modern Biology and Drug Discovery etc. and has achieved more than 3400 citations, with H-index=30, 10 granted international patents. He is currently a member (including Editor-in-Chief, Associate Editor, topic Editor etc.) of the editorial boards of 45 scientific journals and completed editing >70 manuscripts, as well as a reviewer for more than 50 scientific journals and completed reviewing >140 manuscripts.